1. An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer

   • E Pinkerton
   • P Good
   • J Hardy

   Commentary 04 November 2016 Pages: 341 - 343

   

2. Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

   • Vittorio Fusco
   • Alberto Bedogni
   • Giuseppina Campisi

   Letter to the editor 09 March 2016 Pages: 345 - 349

3. Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab

   • Paul de Boissieu
   • Thierry Trenque

   Letter to the editor 28 April 2016 Pages: 351 - 352

4. Response to letter to the Editors—Safety of long-term denosumab therapy

   • Alison T. Stopeck
   • Douglas J. Warner

   Letter to the editor Open access 24 November 2016 Pages: 353 - 355

5. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease

   • Joel B. Epstein
   • Judith E. Raber-Durlacher
   • D. Tzachanis

   Original Article 21 September 2016 Pages: 357 - 364

   

6. Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials

   • Eric J. Roeland
   • Joseph D. Ma
   • Vickie E. Baracos

   Original Article 15 September 2016 Pages: 365 - 369

   

7. Palliative care consultation team on acute wards—an intervention study with pre-post comparisons

   • Maria Friedrichsen
   • Yvonne Hajradinovic
   • Anna Milberg

   Original Article Open access 16 September 2016 Pages: 371 - 380

   

8. Impact of enhanced recovery program on patients with esophageal cancer in comparison with traditional care

   • Lihong Wang
   • Chenjing Zhu
   • Ping Li

   Original Article 10 October 2016 Pages: 381 - 389

   

9. Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study

   • Noor Al-Dasooqi
   • Joanne Bowen
   • Rachel Gibson

   Original Article 20 September 2016 Pages: 391 - 398

   

10. Lost and stranded: the experience of younger adults with advanced cancer

    • Matthew K. Knox
    • Sarah Hales
    • Gary Rodin

    Original Article 27 September 2016 Pages: 399 - 407

11. Quality of life (QOL) and symptom burden (SB) in patients with breast cancer

    • Julia Hamer
    • Rachel McDonald
    • Edward Chow

    Original Article 30 September 2016 Pages: 409 - 419

12. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?

    • Lisa Brice
    • Nicole Gilroy
    • Ian Kerridge

    Original Article 03 October 2016 Pages: 421 - 427

13. Evaluation of the effects and adverse drug reactions of low-dose dexamethasone premedication with weekly docetaxel

    • Rae Young Kang
    • Kyung Sook Yoo
    • Yu Jeung Lee

    Original Article 30 September 2016 Pages: 429 - 437

14. Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor

    • Derek Weycker
    • Xiaoyan Li
    • Gary H. Lyman

    Original Article 12 October 2016 Pages: 439 - 447

15. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia

    • Stephen A. Sands
    • Brian T. Harel
    • Peter D. Cole

    Original Article 10 October 2016 Pages: 449 - 457

    

16. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study

    • Lucksamon Thamlikitkul
    • Vichien Srimuninnimit
    • Nopadol Soparattanapaisarn

    Original Article 06 October 2016 Pages: 459 - 464

    

17. Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up

    • Bárbara Reis Wariss
    • Rejane Medeiros Costa
    • Anke Bergmann

    Original Article 04 October 2016 Pages: 465 - 470

18. Determining best methods to screen for religious/spiritual distress

    • Stephen D. W. King
    • George Fitchett
    • Elizabeth Trice Loggers

    Original Article 06 October 2016 Pages: 471 - 479

19. Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity

    • Yoshitaka Saito
    • Masaki Kobayashi
    • Ken Iseki

    Original Article 03 October 2016 Pages: 481 - 487

    

20. Pathways between physical activity and quality of life in African-American breast cancer survivors

    • Rachel Meadows
    • Timethia Bonner
    • Raheem Paxton

    Original Article 05 October 2016 Pages: 489 - 495

    

21. Barriers to lung cancer care: health professionals’ perspectives

    • J. Dunn
    • G. Garvey
    • S. K. Chambers

    Original Article Open access 10 October 2016 Pages: 497 - 504

    

22. A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer

    • K. H. Park
    • S. Lee
    • Jae Hong Seo

    Original Article 06 October 2016 Pages: 505 - 511

    

23. Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer

    • Nicole K. Behnke
    • Dustin K. Baker
    • Brent A. Ponce

    Original Article 04 October 2016 Pages: 513 - 521

24. Advance directives in patients with advanced cancer receiving active treatment: attitudes, prevalence, and barriers

    • Julie C. McDonald
    • Jeanne M. du Manoir
    • Camilla Zimmermann

    Original Article 07 October 2016 Pages: 523 - 531

    

25. Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer

    • Yi-Hsin Liang
    • Chih-Hsin Wei
    • Kun-Huei Yeh

    Original Article 04 October 2016 Pages: 533 - 539

    

26. Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia

    • Beejal R. Ganti
    • Bernard L. Marini
    • Anthony J. Perissinotti

    Original Article 14 October 2016 Pages: 541 - 547

    

27. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications

    • Stefan Stefanovic
    • Markus Wallwiener
    • Sara Brucker

    Original Article 17 October 2016 Pages: 549 - 558

    

28. A qualitative exploration of oncology nurses’ family assessment practices in Denmark and Australia

    • Elisabeth Coyne
    • Karin B. Dieperink

    Original Article 10 October 2016 Pages: 559 - 566

    

29. Health-related problems in adult cancer survivors: development and validation of the Cancer Survivor Core Set

    • O.P. Geerse
    • K. Wynia
    • A.J. Berendsen

    Original Article Open access 14 October 2016 Pages: 567 - 574

30. The impact of a simplified documentation method for the Edmonton classification system for cancer pain (ECS-CP) on clinician utilization

    • Kimberson Tanco
    • Joseph Arthur
    • Eduardo Bruera

    Original Article 08 October 2016 Pages: 575 - 580

    

31. Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea

    • Thomas Kutner
    • Emily Kunkel
    • U. Margaretha Wallon

    Original Article 12 October 2016 Pages: 581 - 587

    

32. Quality of life trajectories after diagnosis of gynecologic cancer: a theoretically based approach

    • Brian D. Gonzalez
    • Sharon L. Manne
    • Mark Morgan

    Original Article 19 October 2016 Pages: 589 - 598

    

33. The role of palliative care in the last month of life in elderly cancer patients

    • Tarek Assi
    • Elie El Rassy
    • Joseph Kattan

    Original Article 13 October 2016 Pages: 599 - 605

    

34. A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

    • Midori Nakagaki
    • Michael Barras
    • Glen A. Kennedy

    Original Article 13 October 2016 Pages: 607 - 613

    

35. The Enhancing Connections-Telephone study: a pilot feasibility test of a cancer parenting program

    • Frances Marcus Lewis
    • Kristin A. Griffith
    • Nai-ching Chi

    Original Article 21 October 2016 Pages: 615 - 623

    

36. Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer

    • S. C. Agasi-Idenburg
    • M. S. Y. Thong
    • N. K. Aaronson

    Original Article 21 October 2016 Pages: 625 - 632

    

37. Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer

    • Yu Ke
    • Terence Ng
    • Alexandre Chan

    Original Article 22 October 2016 Pages: 633 - 643

38. The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids

    • Sebastiano Mercadante
    • Claudio Adile
    • Alessandra Casuccio

    Original Article 15 October 2016 Pages: 645 - 649

    

39. Dermatologic events from EGFR inhibitors: the issue of the missing patient voice

    • Bernd Tischer
    • Renate Huber
    • Mario E. Lacouture

    Review Article Open access 07 October 2016 Pages: 651 - 660

    

40. The use of opioids in cancer patients with renal impairment—a systematic review

    • Tonje A. Sande
    • Barry J. A. Laird
    • Marie T. Fallon

    Review Article 15 October 2016 Pages: 661 - 675

    

41. Do-not-resuscitate orders in cancer patients: a review of literature

    • Aart Osinski
    • Gerard Vreugdenhil
    • Johannes G. van der Hoeven

    Review Article 22 October 2016 Pages: 677 - 685

    

42. A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions

    • Sharon Elad
    • Vinisha Ranna
    • Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)

    Review Article 16 November 2016 Pages: 687 - 700